Microencapsulation of Cannabidiol in Liposomes as Coating for Cellulose for Potential Advanced Sanitary Material
Source abstract
Abstract
The microencapsulation of the cannabidiol and its integration into the tampon can eliminate vaginal inflammation, which at the same time lead to relaxation of the abdominal muscles. The tampon, which contains the active substance cannabidiol (CBD), was developed as an advanced fibrous composite for sanitary application. The active substances were microencapsulated, and, as a carrier, liposomes micro/nano capsules were used. The CBD liposome formulation was analyzed by particle size, polydispersity index, zeta potential, and encapsulation efficiency. Particle size of the CBD liposome liquid formulation was increased by 19%, compared to the liposome liquid formulation and the encapsulation efficiency of CBD in liposome particles, which was 90%. The CBD liposome formulation was applied to cellulose material. The composition of the fibrous composite material was evaluated by Fourier transform infrared spectroscopy, the fiber morphology was analyzed by scanning electron spectroscopy, while the bioactive properties were assessed by antioxidant efficiency, antimicrobial properties, and desorption kinetics. CBD liposome functionalized tampons have both antioxidant and antimicrobial properties. Antimicrobial properties were more pronounced against Gram-positive bacteria. The desorption kinetics of the CBD liposome immobilized on the surface of the composite material was studied using antioxidant activity in the desorption bath. The prepared CBD liposome functionalized tampon additionally shows higher biodegradability compared to references. This high-quality, biodegradable sanitary material based on microencapsulated CBD components as a functional coating provides a platform for many different applications besides medical textiles, also for packaging, pharmaceuticals, paper and wood-based materials, etc.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cannabis and Cannabinoid Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Engineering Materials and Design, Faculty of Mechanical Engineering, University of Maribor, Smetanova 17, SI-2000 Maribor, Slovenia
Scientific Research Centre Bistra Ptuj, Slovenski trg 6, SI-2250 Ptuj, Slovenia
References (52)
Show source-provided references
1. Dysmenorrhea and related disorders10.12688/f1000research.11682.1 ↗
2. Evaluation of vaginal pH for detection of bacterial vaginosis
3. Bruni, N., Della-Pepa, C., Oliaro-Bosso, S., Pessione, E., Gastaldi, D., and Dosio, F. (2018). Cannabinoid delivery systems for pain and inflammation treatment. Molecules, 23.10.3390/molecules23102478 ↗
4. Creagh, S., Warden, D., Latif, M., and Paydar, A. (2018). The new classes of synthetic illicit drugs can significantly harm the brain: A neuro imaging perspective with full review of MRI findings. Clin. Radiol. Imaging J., 2.10.23880/CRIJ-16000116 ↗
5. Cannabidiol in anxiety and sleep: A large case series10.7812/TPP/18-041 ↗
6. Cannabidiol (Cbd) and its analogs: A review of their effects on inflammation10.1016/j.bmc.2015.01.059 ↗
7. Cannabinoids in the management of difficult to treat pain10.2147/TCRM.S1928 ↗
8. Mücke, M., Phillips, T., Radbruch, L., Petzke, F., and Häuser, W. (2018). Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst. Rev., 3.10.1002/14651858.CD012182.pub2 ↗
9. Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon10.1042/CS20171288 ↗
10. Probing the antioxidant activity of δ9-tetrahydrocannabinol and cannabidiol in cannabis sativa extracts10.1039/C9AN00890J ↗
11. Preedy, V.R. (2017). Cannabidiol as an antioxidant. Handbook of Cannabis and Related Pathologies, Academic Press. Chapter E12.
12. Pellati, F., Borgonetti, V., Brighenti, V., Biagi, M., Benvenuti, S., and Corsi, L. (2018). Cannabis sativa L. and nonpsychoactive cannabinoids: Their chemistry and role against oxidative stress, inflammation, and cancer. Biomed. Res. Int., 2018.10.1155/2018/1691428 ↗
13. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta9-tetrahydrocannabinol, cannabidiol and Delta9-tetrahydrocannabivarin10.1038/sj.bjp.0707442 ↗
14. Cannabidiol and (–)Delta9-tetrahydrocannabinol are neuroprotective antioxidants10.1073/pnas.95.14.8268 ↗
15. Ayat, Z., Mohamed, K., Kim, H., Kim, E., Frank, C., Black, T., Jadhav, P., Holbrook, L., and Laprairie, R. (2020). In vitro and in vivo pharmacological activity of minor cannabinoids isolated from cannabis sativa. Sci. Rep., 10.10.1038/s41598-020-77175-y ↗
16. Nichol, K., Stott, C., Jones, N., Gray, R.A., Bazelot, M., and Whalley, B.J. (2019). The proposed multimodal mechanism of action of cannabidiol (CBD) in epilepsy: Modulation of intracellular calcium and adenosine-mediated signaling. Neurology, 92.10.1212/WNL.92.15_supplement.P5.5-007 ↗
17. Cannabis treatments in obstetrics and gynecology: A historical review10.1300/J175v02n03_02 ↗
18. Safety and side effects of cannabidiol, a cannabis sativa constituent10.2174/157488611798280924 ↗
19. Cannabidiol adverse effects and toxicity10.2174/1570159X17666190603171901 ↗
20. Liposomal drug delivery systems: From concept to clinical applications10.1016/j.addr.2012.09.037 ↗
21. Arroyo-Ariza, D., Suesca, E., Leidy, C., and Gonzalez, J.M. (2020). Sulfatide-rich liposome uptake by a human-derived neuroblastoma cell line. Processes, 8.10.3390/pr8121615 ↗
22. Liposome as a carrier for advanced drug delivery10.3923/pjbs.2006.1181.1191 ↗
23. Lipid nanoparticles for improved topical application of drugs for skin diseases10.1016/j.addr.2007.04.006 ↗
24. Liposomes and skin: From drug delivery to model membranes
25. Ethosomal nanocarriers: The impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials10.2147/IJN.S105016 ↗
26. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products10.1016/j.ijpharm.2008.10.003 ↗
27. Cannabidiol—Transdermal delivery and anti-inflammatory effect in a murine model10.1016/j.jconrel.2003.09.001 ↗
28. Çağdaş, M., Sezer, A.D., and Bucak, S. (2014). Liposomes as potential drug carrier systems for drug delivery. Application of Nanotechnology in Drug Delivery, BoD—Books on Demand.10.5772/58459 ↗
29. A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems10.1039/D0RA03491F ↗
30. Donnsky, M., and Winnicki, R. (2015). Terpene and Cannabinoid Formulations. (Wo2015068052a2), U.S. Patent.
31. (2020, November 19). Foria. Available online: https://foriapleasure.com/products/relief.
32. (2020, April 15). Daye. Available online: https://yourdaye.com.
33. Nano-encapsulation of fish oil in nano-liposomes and its application in fortification of yogurt10.1016/j.foodchem.2016.08.022 ↗
34. (2020, November 19). Zetasizer Nano. Available online: https://manualzilla.com/doc/5827440/manual-zetasizer-nano-user-manual-man0485-1.1.
35. (2020, November 19). Anton Paar. Available online: https://wiki.anton-paar.com/en/the-principles-of-dynamic-light-scattering.
36. Zeta potential measurement10.1007/978-1-60327-198-1_6 ↗
37. Surface characterization and adsorption abilities of cellulose fibers10.1002/pen.11532 ↗
38. Evaluation of in vitro release kinetics and mechanisms of curcumin-loaded cockle shell-derived calcium carbonate nanoparticles10.15419/bmrat.v6i12.580 ↗
39. Antioxidant activity: What do we measure?10.18388/abp.1999_4180 ↗
40. Smith, E.J., Williams, J.T., Walsh, S.E., and Painter, P. (2010). Comparison of antimicrobial textile treatments. Medical and Healthcare Textiles, Woodhead Publishing Series in Textiles.10.1533/9780857090348.38 ↗
41. Rapid evaluation of edible hemp oil quality using NMR and ft-IR spectroscopy10.1016/j.molstruc.2018.09.057 ↗
42. Role of antioxidants and natural products in inflammation10.1155/2016/5276130 ↗
43. Supercritical CO2 extract of cinnamomum zeylanicum: Chemical characterization and antityrosinase activity10.1021/jf071938f ↗
44. Antibacterial activity of the essential oils of salvia officinalis L. and salvia triloba L. cultivated in south Brazil10.1016/j.foodchem.2005.09.078 ↗
45. Plant products as antimicrobial agents10.1128/CMR.12.4.564 ↗
46. Fusogenic liposomes increase the antimicrobial activity of vancomycin against staphylococcus aureus biofilm10.3389/fphar.2019.01401 ↗
47. Liposome: Classification, preparation, and applications10.1186/1556-276X-8-102 ↗
48. Enhancement of nisin, lysozyme, and monolaurin antimicrobial activities by ethylenediaminetetraacetic acid and lactoferrin10.1016/S0168-1605(03)00172-7 ↗
49. Biodegradable polymers and environmental interaction10.1002/pen.10294 ↗
50. Long—Term storage and cannabis oil stability
51. Degradation of sterols, triacylglycerol, and phospholipids by soil microorganisms
52. Cooperation of simulation and data model for performance analysis of complex systems10.2507/IJSIMM18(4)491 ↗